Aarti Drugs Ltd

Aarti Drugs Ltd

Next 500 2024
+ 9 More
+ 9 More
OVERVIEW
FINANCIALS
NEWS

About

Aarti Drugs is a leading Indian pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. They serve various therapeutic segments such as antibiotics, anti-protozoal, and anti-inflammatory. Their focus on quality and compliance has established them as a trusted supplier in both domestic and international markets.

Incorporation Year: 1984
Headquarters: Mumbai, India
Top Management: Rashesh C. Gogri (MD)
Industry: Pharma

Featured In Fortune India Ranking

#467(2021)
Next 500 India
#110(2024)#25(2023)#8(2021)#127(2020)#157(2019)#199(2018)#212(2017)#189(2016)#320(2015)
#110(2024)#25(2023)#8(2021)#127(2020)#157(2019)#199(2018)#212(2017)#189(2016)#320(2015)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
2,507
(INR Cr)
Net Operating Income
2,529
(INR Cr)
Assets
1,849
(INR Cr)
Profit
171
(INR Cr)
Net Worth
1,282
(INR Cr)

Fortune India Coverage

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
2507
-7.8%
2720
5.2%
2586
18.9%
2174
16.7%
1863
20.2%
1550
19.3%
1300
8.3%
1200
4.8%
1145
1.8%
1125
16.3%
967
14.1%
848
27.8%
663
27.6%
520
9.2%
476
27.4%
374
-
Net Operating Income
(INR Cr)
2529
-6.90%
2716
9.14%
2489
15.49%
2155
19.31%
1806
15.71%
1561
25.51%
1244
4.05%
1195
4.85%
1140
3.92%
1097
0.00%
972
17.68%
826
25.25%
659
32.80%
501
4.71%
479
25.23%
382
22.33%
Profit
(INR Cr)
171
3.1%
166
-18.9%
205
-26.9%
280
98.3%
141
57.6%
90
9.0%
82
0.6%
82
19.0%
69
-11.0%
77
25.2%
62
36.4%
45
101.4%
22
-5.6%
24
-15.8%
28
74.9%
16
-
Assets
(INR Cr)
1849
2.5%
1805
13.0%
1598
23.6%
1293
20.3%
1075
0.1%
1074
4.2%
1030
14.1%
903
5.9%
853
11.0%
769
27.1%
605
17.1%
516
13.0%
457
6.0%
431
26.6%
340
4.6%
325
-
Net Worth
(INR Cr)
1282
7.5%
1192
15.1%
1036
13.5%
913
40.0%
652
20.1%
543
19.3%
455
13.8%
400
12.0%
357
16.0%
308
0.0%
251
20.9%
208
17.6%
176
12.8%
163
11.4%
146
18.6%
123
10.7%
Employee Cost
(INR Cr)
91
12.6%
80
16.1%
69
5.2%
66
7.4%
61
12.5%
55
4.6%
52
8.7%
48
19.3%
40
20.8%
33
16.7%
29
10.2%
26
11.1%
23
16.8%
20
34.9%
15
23.2%
12
-
Interest Cost
(INR Cr)
38372426374438404842373125171926
Cash & Bank Balance
(INR Cr)
992210864454435593
Total Debt
(INR Cr)
564609543351389507546480483448342296272267189192

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 6.8%6.1%7.9%12.9%7.6%5.8%6.3%6.8%6.0%6.9%6.4%5.3%3.4%4.6%5.9%4.3%
Profit As % Of Assets 9.3%9.2%12.8%21.7%13.2%8.4%8.0%9.1%8.1%10.1%10.2%8.8%4.9%5.5%8.3%5.0%
Profit As % Of Networth 13.4%14.0%19.8%30.7%21.7%16.5%18.1%20.4%19.2%25.1%24.6%21.8%12.7%14.6%19.3%13.1%
Interest Cost to EBITDA % 11.8%12.0%7.2%6.0%14.1%20.6%19.0%21.0%26.7%24.5%24.8%25.1%32.2%24.8%22.6%39.8%
Debt to Equity Ratio 0.440.510.520.380.600.931.201.201.351.451.361.421.541.641.291.56
RONW 13.9%14.9%21.0%35.8%23.7%18.0%19.2%21.6%20.7%25.1%26.9%23.6%13.5%15.0%20.0%14.4%
ROCE 15.0%15.4%20.3%33.4%20.7%16.6%16.9%17.8%17.7%19.3%21.9%19.9%13.7%13.0%19.9%16.1%